BUZZ-U.S. STOCKS ON THE MOVE-Replimune, Snowflake, Virpax Pharmaceuticals

Reuters11-25 22:20
BUZZ-U.S. STOCKS ON THE MOVE-Replimune, <a href="https://laohu8.com/S/SNOW">Snowflake</a>, Virpax Pharmaceuticals

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter: https://refini.tv/3LI4BU7

The Morning News Call newsletter: https://refini.tv/3dKUyB8

Dow contracts touched a record high on Monday and led gains among U.S. stock index futures, on investor optimism driven by Scott Bessent's nomination as Treasury Secretary in the incoming Trump administration..N ** Elevai Labs Inc ELAB.O:BUZZ - Falls after announcing 1-for-200 stock split ([Full story])

** Virpax Pharmaceuticals Inc VRPX.O:BUZZ - Declines after Nasdaq non-compliance notice [Full story]

** Snowflake Inc SNOW.N:BUZZ - Rises after brokerage Wedbush upgrades to 'outperform' ([Full story])

** GE Vernova Inc GEV.N:BUZZ - Rises after RBC Capital Markets raises PT ([Full story])

** Durect Corp DRRX.O:BUZZ - Rises after selling Alzet pumps for $17.5 mln ([Full story])

** Newmont Corp NEM.N:

** Barrick Gold Corp ABX.TO: ** Gold Fields Ltd GFI.N: ** Harmony Gold Mining Co Ltd HMY.N:

BUZZ - Gold miners fall as bullion prices succumb to profit taking ([Full story])

** EQT Corp EQT.N:BUZZ - Rises after $3.5 bln joint venture with Blackstone ([Full story])

** Summit Materials SUM.N:BUZZ - Strikes $11.5 bln deal with Quikrete; shares down ([Full story])

** Replimune Group Inc REPL.O:BUZZ - Slips after $125 mln stock offering announced ([Full story])

** Biohaven Ltd BHVN.N:BUZZ - Falls as genetic disorder drug fails to meet goal in late-stage study ([Full story])

** Cassava Sciences Inc SAVA.O:BUZZ - Shares drop as Alzheimer's drug fails in late-stage study ([Full story])

** EnLink Midstream LLC ENLC.N:BUZZ - Up on sale of remaining shares to ONEOK in $4.3 bln deal ([Full story])

(Compiled by Rajarshi Roy and Kritika Lamba in Bengaluru)

((Kritika.Lamba@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment